XML 18 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 05, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-33093  
Entity Registrant Name LIGAND PHARMACEUTICALS INCORPORATED  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0160744  
Entity Address, Address Line One 555 Heritage Drive, Suite 200  
Entity Address, City or Town Jupiter  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33458  
City Area Code 858  
Local Phone Number 550-7500  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol LGND  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   18,268,950
Amendment Flag false  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Entity Central Index Key 0000886163  
Current Fiscal Year End Date --12-31